Slideshow

The Artificial Sweetener Paradox: Weight Gain and Metabolic Dysfunction?

A new meta-analysis finds that routine intake of artificial sweeteners is linked to the opposite of the intended effect.

The Academy of Nutrition and Dietetics' current position on nonnutritive sweeteners is that they may help limit inatke of energy in an effort to manage weight or blood glucose. The consumption of artificial sweeteners, including aspartame, sucralose, and stevia, however, has been associated with both weight gain and incident obesity. Existing evidence, from both randomized controlled trials and observational studies, is conflicting.The objective of the meta-analysis summarized in the short slide show above was to determine whether "routine consumption of nonnutritive sweeteners by adults and adolescents [is] associated with adverse long-term cardiometabolic effects in RCTs and prospective cohort studies."

References:

1. Swithers SE. Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements. Trends Endocrinol Metab. 2013;24:431–41.

2. Nettleton JE, Reimer RA, Shearer J. Reshaping the gut microbiota: Impact of low calorie sweeteners and the link to insulin resistance? Physiol Behav. 2016; 164(Pt B):488–93

3. Azad MB, Abou-Setta AM, Chauhan BF, et al. Nonnutritive sweeteners and cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials and prospective cohort studies. CMAJ. 2017;189:E929-E939. doi: 10.1503/cmaj.161390.

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Matthew Weir, MD: Prioritizing Cardiovascular Risk in Chronic Kidney Disease | Image Credit: University of Maryland
Erin Michos, MD: HFpEF in Women and Sex-Specific Therapeutic Approaches | Image Credit: Johns Hopkins
© 2024 MJH Life Sciences

All rights reserved.